Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, anemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, sickle cell disease	Recruiting	Phase 2	2026-03-10		NCT03587272

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alberta Children's Hospital	18
Ann & Robert H Lurie Children's Hospital of Chicago	76
Children's Hospital at Montefiore	6
Columbia University	375
Levine Children's Hospital	2
Nationwide Children's Hospital	97
Robert Nickel	1
The Hospital for Sick Children	162

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Alberta Children's Hospital	Calgary	Canada	70
Ann & Robert H. Lurie Children's Hospital of Chicago	Chicago	United States	144
Children's National Health System	Washington D.C.	United States	19
Columbia University	New York	United States	154
Levine Children's Hospital	Charlotte	United States	10
Nationwide Children's Hospital	Columbus	United States	309
The Hospital For Sick Children	Toronto	Canada	94